Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated August 4, 2023, please note that the audio recording of the earnings call on the unaudited financial results for the first quarter ended June 30, 2023, held on August 14, 2023, at 8.30 AM (IST), has been uploaded on our website on the following web-link: https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/audio-or-video-recordings/

pdf

Aurobindo Pharma Ltd.

12 Aug 2023

1215.00

0.50%

Investor Presentation

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on un-audited financial results for the first quarter ended June 30, 2023.

pdf

Aurobindo Pharma Ltd.

01 Jun 2023

1215.00

0.50%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please refer to our letter dated May 19, 2023, wherein we intimated about the schedule of Investors/ Analysts call on May 29, 2023. We are attaching herewith the Transcript of the said analyst / investor call on the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2023, and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/conference-call-transcripts/

pdf

Aurobindo Pharma Ltd.

29 May 2023

1215.00

0.50%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated May 19, 2023, please note that the audio recording of the earnings call on the audited financial results for the fourth quarter and year ended March 31, 2023, held on May 29, 2023, at 8.30 AM (IST), has been uploaded on our website on the following web-link: https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/audio-or-video-recordings/

pdf

Aurobindo Pharma Ltd.

27 May 2023

1215.00

0.50%

Investor Presentation

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Please refer to our letter dated May 19, 2023 wherein we intimated the schedule of Investors/ Analysts call on May 31, 2023. In this connection, we enclose herewith the presentation that would be used in the Investors / Analysts call on the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2023. The presentation is also being uploaded in the following weblink of the Company.

pdf

Is Aurobindo Pharma Ltd. worth buying?

1260 Votes:

Buy 80.24%

Sell 13.73%

Hold 6.03%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf